Overview

Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19

Status:
Recruiting
Trial end date:
2021-03-20
Target enrollment:
Participant gender:
Summary
Ivermectin showed a strong viricidal effect upon covid19 virus in vitro as proved by many authors according to many studies , covid virus stay in postnasal space for 4 days before starting general manifestation, so ivermectin mucoadhesive nanosuspension sprayed inside the nose and post nasal space may help in early management of covid19 and may play a great rule in prophylaxis as well
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
South Valley University
Treatments:
Ivermectin